<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72366">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02136342</url>
  </required_header>
  <id_info>
    <org_study_id>LYS-I-01</org_study_id>
    <nct_id>NCT02136342</nct_id>
  </id_info>
  <brief_title>Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer</brief_title>
  <official_title>Phase 1 Trial Evaluating Tolerability and Pharmacokinetics of Chlorogenic Acid for Injection in Patients With Advanced Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Academy of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Chinese Academy of Medical Sciences</source>
  <oversight_info>
    <authority>China: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to explore if chlorogenic acid is safe in patients with cancer.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Number of adverse events</measure>
    <time_frame>within the first 60 days after the first dose of chlorogenic acid</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>dose-limiting toxicity</measure>
    <time_frame>within the first 30 days after the first dose of chlorogenic acid</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maximum tolerated dose</measure>
    <time_frame>within the first 30 days after the first dose of chlorogenic acid</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area under the plasma concentration versus time curve (AUC) and Peak Plasma Concentration (Cmax) of  chlorogenic acid</measure>
    <time_frame>within the first 30 days after the first dose of chlorogenic acid</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>improvement in cancer-related symptoms and quality of life</measure>
    <time_frame>within 1 year after the first dose of chlorogenic acid</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in number of red blood cell and level of hemoglobin</measure>
    <time_frame>within 1 year after the first dose of chlorogenic acid</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>change in the diameters of lymph node metastasis</measure>
    <time_frame>within 1 year after the first dose of chlorogenic acid</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>change in levels of tumor markers</measure>
    <time_frame>within 1 year after the first dose of chlorogenic acid</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <condition>Advanced Cancer</condition>
  <arm_group>
    <arm_group_label>chlorogenic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>chlorogenic acid</intervention_name>
    <arm_group_label>chlorogenic acid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  advanced cancer with no effective treatment

          -  Karnofsky performance status no less than 70

          -  adequated organ function

          -  informed consent

        Exclusion Criteria:

          -  allergic to chlorogenic acid

          -  persistent toxicities from previous treatment (no less than grade 2)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuankai Shi, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cancer Institute and Hospital, Chinese Academy of Medical Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sheng Yang, Dr.</last_name>
    <phone>86-10-87788532</phone>
    <email>medart@yeah.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yutao Liu, Dr.</last_name>
    <phone>86-10-87788119</phone>
  </overall_contact_backup>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 12, 2014</lastchanged_date>
  <firstreceived_date>May 9, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Academy of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Shi Yuankai</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>no available effective treatment</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
